ENTRY       D10991                      Drug
NAME        Suptavumab (USAN/INN)
SEQUENCE    (Heavy chain)
            EVQLVESGGD LVQPGRSLRL SCVASGFTFD DYAMHWVRQA PGKGLEWVSG VSWSGSTVGY
            ADSVKGRFTV SRDNAQKSLY LQMNSLRAED TALYYCVKDA YKFNYYYYGL DVWGQGTTVT
            VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKK VEPKSCDKTH TCPPCPAPEL
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
            QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS
            RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PG
            (Light chain)
            EIVMTQSPAT LSVSPGERAT LSCRASQTIL SNLAWYLQKP GQAPRLLIYG ASTRATGLPA
            RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YNNWPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H150-H206, H226-L214, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'150^H'206, H'226-L'214, H'267-H'327, H'373-H'431, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Prevention of medically attended lower raspiratory tract disease due to respiratory syncytial virus
TARGET      RSV F protein [KO:K19261]
BRITE       Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               RSV F protein
                D10991  Suptavumab (USAN/INN)
DBLINKS     CAS: 1629615-23-1
            PubChem: 350078337
///
